awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28080984-F36A2649-E477-4E1E-A24C-053138C29FC2
Q28080984-F36A2649-E477-4E1E-A24C-053138C29FC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080984-F36A2649-E477-4E1E-A24C-053138C29FC2
Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
P2860
Q28080984-F36A2649-E477-4E1E-A24C-053138C29FC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080984-F36A2649-E477-4E1E-A24C-053138C29FC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0769f5fcf7f1b33436b8bce60962c13957f71f32
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.